Details

Autor(en) / Beteiligte

• Sampor, C
• Guthmann, M D
• Scursoni, A
• Cacciavillano, W
• Torbidoni, A
• Galluzzo, L
• Camarero, S
• Lopez, J
• de Dávila, M T G
• Fainboim, L
• Chantada, G L

Titel

Immune response to racotumomab in a child with relapsed neuroblastoma

Ist Teil von

• Frontiers in oncology, 2012, Vol.2, p.195-195

Ort / Verlag

Switzerland: Frontiers Media S.A

Erscheinungsjahr

2012

Quelle

EZB-FREE-00999 freely available EZB journals

Beschreibungen/Notizen

• Immunotherapy targeting ganglioside antigens is a powerful tool for the treatment of high risk neuroblastoma. However, only treatment with anti-GD2 antibodies has been used in clinical practice and other options may be pursued. We report the use of racotumomab, an anti-idiotype vaccine against N-glycolyl neuraminic acid (NeuGc)- containing gangliosides, eliciting an immune response in a child with relapsed neuroblastoma expressing the NeuGcGM3 ganglioside.